Table 2 Determinants of very high erythropoietin levels.

From: Serum erythropoietin and its determinants and associations in patients with haemoglobin E β-thalassaemia

Characteristic

Number (%) with very high EPO level

Unadjusted odds ratio (OR), 95%CI, and p-value

Adjusted odds ratio (AOR), 95%CI, and p-value

Gender

 Male (n = 22)

16 (72.7%)

OR = 3.48

95%CI = 1.07–11.3

p = 0.035

AOR = 6.911

95%CI = 0.90–52.7

p = 0.062

 Female (n = 30)

13 (43.3%)

Age category

 Children (n = 17)

14 (82.4%)

OR = 6.22

95%CI = 1.51–25.6

p = 0.007

AOR = 0.75

95%CI = 0.03–20.0

p = 0.868

 Adults (n = 35)

15 (42.9%)

Age at diagnosis

  =  < 4 years (n = 31)

21 (67.7%)

OR = 3.41

95%CI = 1.07–10.8

p = 0.035

AOR = 5.10

95%CI = 0.77–33.6

p = 0.090

  > 4 years (n = 21)

8 (38.1%)

No. of transfusions

  < 100 (n = 15)

11 (73.3%)

OR = 2.90

95%CI = 0.78–10.7

p = 0.104

AOR = 1.22

95%CI = 0.03–42.0

p = 0.909

  > 100 (n = 37)

18 (48.6%)

Transfusion dependency

 Transfusion dependent (n = 32)

17 (53.1%)

OR = 0.75

95%CI = 0.24–2.34

p = 0.627

AOR = 7.41

95%CI = 0.29–185.6

p = 0.223

 Non-transfusion dependent (n = 20)

12 (60.0%)

Pre-transfusion haemoglobin

  < 7 g/dL (n = 29)

18 (62.1%)

OR = 1.78

95%CI = 0.58–5.41

p = 0.304

AOR = 4.00

95%CI = 0.72–22.0

p = 0.111

  >  = 7 g/dL (n = 23)

11 (47.8%)

Splenectomy

 Non-splenectomy (n = 36)

25 (69.4%)

OR = 6.81

95%CI = 1.79–25.9

p = 0.003

AOR = 15.9

95%CI = 1.80–140.9

p = 0.013

 Splenectomised (n = 16)

4 (25.0%)

Hydroxyurea treatment

 On hydroxyurea (n = 13)

10 (76.9%)

OR = 3.50

95%CI 0.83–14.73

p = 0.076

AOR = 6.35

95%CI = 0.73–54.9

p = 0.093

 Not on hydroxyurea (n = 39)

19 (48.7%)

Ferritin

  < 1000 ng/mL (n = 20)

14 (70.0%)

OR = 2.64

95%CI = 0.81–8.62

p = 0.102

AOR = 4.61

95%CI = 0.42–50.3

p = 0.210

  >  = 1000 ng/mL (n = 32)

15 (46.9%)

  1. *EPO, erythropoietin; OR, Odds ratio; AOR, Adjusted odds ratio; CI, confidence interval.